Forbes: HPV vaccination still going strong after 10 years

New findings from one of the longest follow-up studies of the four-strain human papilloma virus (HPV) show that the vaccine is safe and effective, especially in those who received the vaccine at a younger age.

“These findings justify efforts to vaccinate subjects at the earliest opportunity,” said Dr. Daron Ferris, professor of obstetrics and gynecology at the Medical College of Georgia at Augusta University. “Moreover, by vaccinating preadolescents before exposure to HPV, the full potential of the vaccine is more likely to be realized.”

The research was featured in multiple national publications, including Forbes, Yahoo News! and MSN.

Forbes: HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens

Nov. 22, 2017